Clinical Trial Update: Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus [Phase 2]

View source ↗

Summary

Phase 2 trial of metformin hydrochloride to prevent esophageal cancer in patients with Barrett's esophagus; the trial completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Esophageal Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Barrett Esophagus, Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-07-21